Literature DB >> 20921521

Gender-associated differences of perforin polymorphisms in the susceptibility to multiple sclerosis.

Montse Camiña-Tato1, Carlos Morcillo-Suárez, Marta F Bustamante, Israel Ortega, Arcadi Navarro, Aura Muntasell, Miguel López-Botet, Alex Sánchez, Paco Carmona, Eva Julià, María Teresa Tortola, Laura Audí, Jorge R Oksenberg, Roland Martin, Xavier Montalban, Manuel Comabella.   

Abstract

The granule-dependent exocytosis pathway is an important mechanism to induce apoptosis by CD8(+) T cells and NK cells and involves lytic molecules such as perforin. In the current study, we investigated the perforin 1 gene (PRF1) as a candidate for multiple sclerosis (MS) susceptibility in the Spanish population. We genotyped three PRF1 single nucleotide polymorphisms (rs885822, rs10999426, and rs3758562) in 420 patients with MS and 512 controls. Associations of PRF1 polymorphisms with the disease were restricted to male patients with MS, and the finding was consistently observed at the allele, genotype, and haplotype levels. Gender-associated differences were validated in an additional replication cohort comprised of 292 MS cases and 300 controls. In addition, we identified minor risk haplotypes strongly associated with male patients having primary progressive MS (PPMS). Further characterization of male patients with PPMS carrying the risk haplotypes by means of gene expression microarrays revealed overrepresentation of the cell killing gene ontology category among downregulated genes in these patients compared with male patients with PPMS carrying protective haplotypes. Moreover, PRF1 mRNA expression levels were significantly lower in patients with risk haplotypes, and changes in perforin protein expression by CD8(+) T cells mirrored those observed in gene expression. These findings suggest a gender dimorphism in the PRF1 association with MS and point to the presence of a generalized defect in the expression of genes that code for proteins involved in cell killing in a subgroup of male patients with PPMS.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20921521     DOI: 10.4049/jimmunol.1000102

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  11 in total

Review 1.  Differential diagnosis of Mendelian and mitochondrial disorders in patients with suspected multiple sclerosis.

Authors:  James D Weisfeld-Adams; Ilana B Katz Sand; Justin M Honce; Fred D Lublin
Journal:  Brain       Date:  2015-01-29       Impact factor: 13.501

2.  Budesonide mitigates pathological changes in animal model Of COPD through reducing neutrophil elastase expression.

Authors:  Lihong Wang; Bin Zhang; Zhu Li; Junhong Li; Qing Liu; Wuzhuang Sun
Journal:  Int J Clin Exp Med       Date:  2015-04-15

3.  Heterozygosity for the common perforin mutation, p.A91V, impairs the cytotoxicity of primary natural killer cells from healthy individuals.

Authors:  Imran G House; Kevin Thia; Amelia J Brennan; Richard Tothill; Alexander Dobrovic; Wei Z Yeh; Richard Saffery; Zac Chatterton; Joseph A Trapani; Ilia Voskoboinik
Journal:  Immunol Cell Biol       Date:  2015-03-17       Impact factor: 5.126

4.  Long-term outcome of patients with virus-negative chronic myocarditis or inflammatory cardiomyopathy after immunosuppressive therapy.

Authors:  Felicitas Escher; Uwe Kühl; Dirk Lassner; Wolfgang Poller; Dirk Westermann; Burkert Pieske; Carsten Tschöpe; Heinz-Peter Schultheiss
Journal:  Clin Res Cardiol       Date:  2016-06-16       Impact factor: 5.460

5.  A case report of novel mutation in PRF1 gene, which causes familial autosomal recessive hemophagocytic lymphohistiocytosis.

Authors:  Mohammad Reza Bordbar; Farzaneh Modarresi; Mohammad Ali Farazi Fard; Hassan Dastsooz; Nader Shakib Azad; Mohammad Ali Faghihi
Journal:  BMC Med Genet       Date:  2017-05-03       Impact factor: 2.103

6.  Familial Hemophagocytic Lymphohistiocytosis Secondary to PRF1 Mutation.

Authors:  Albaraa T Alfaraidi; Abdulaziz A Alqarni; Mohammed T Aqeel; Turki A Albalawi; Ahmed S Hejazi
Journal:  Case Rep Hematol       Date:  2021-12-29

7.  Perforin expression by CD4+ regulatory T cells increases at multiple sclerosis relapse: sex differences.

Authors:  Marta Tejera-Alhambra; Bárbara Alonso; Roseta Teijeiro; Rocío Ramos-Medina; Carol Aristimuño; Larissa Valor; Clara De Andrés; Silvia Sánchez-Ramón
Journal:  Int J Mol Sci       Date:  2012-06-01       Impact factor: 6.208

8.  Transcriptomic profile reveals gender-specific molecular mechanisms driving multiple sclerosis progression.

Authors:  Haritz Irizar; Maider Muñoz-Culla; Lucia Sepúlveda; Matías Sáenz-Cuesta; Álvaro Prada; Tamara Castillo-Triviño; Gorka Zamora-López; Adolfo López de Munain; Javier Olascoaga; David Otaegui
Journal:  PLoS One       Date:  2014-02-28       Impact factor: 3.240

9.  Sex-biased chromatin and regulatory cross-talk between sex chromosomes, autosomes, and mitochondria.

Authors:  Katherine Silkaitis; Bernardo Lemos
Journal:  Biol Sex Differ       Date:  2014-01-15       Impact factor: 5.027

10.  High Perforin-Positive Cardiac Cell Infiltration and Male Sex Predict Adverse Long-Term Mortality in Patients With Inflammatory Cardiomyopathy.

Authors:  Felicitas Escher; Uwe Kühl; Dirk Lassner; Andrea Stroux; Ulrich Gross; Dirk Westermann; Burkert Pieske; Wolfgang Poller; Heinz-Peter Schultheiss
Journal:  J Am Heart Assoc       Date:  2017-08-18       Impact factor: 5.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.